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We consider insomnia a disorder of waking rather than a disorder of sleep. This review
examines the role of the reticular activating system, especially the pedunculopontine
nucleus, in the symptoms of insomnia, mainly representing an overactive waking drive.
We determined that high frequency activity during waking and REM sleep is controlled by
two different intracellular pathways and channel types in PPN cells. We found three
different PPN cell types that have one or both channels and may be active during waking
only, REM sleep only, or both. These discoveries point to a speciﬁc mechanism and novel
therapeutic avenues for insomnia.
& 2015 Brazilian Association of Sleep. Production and Hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Insomnia – symptoms, etiology, and
manifestations
We consider that although insomnia is called a “sleep
disorder”, it is actually a “waking disorder”, in which the
waking system is overactive, intruding excessively into sleep
time. Perhaps in treating insomnia, we should not be trying toep. Production and Hosti
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an Association of Sleep.increase sleep but rather to decrease arousal. Insomnia is
termed “primary” if it is not related to some other medical or
psychiatric condition [1]. The American Academy of Sleep
Medicine deﬁnes insomnia as a persistent difﬁculty with
sleep initiation, duration, consolidation, or quality that
occurs despite adequate opportunity and circumstances for
sleep, and results in some form of daytime impairment [1].ng by Elsevier B.V. This is an open access article under the CC BY-
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disorders such as schizophrenia, bipolar disorder, and major
depression, in which insomnia is termed “secondary”. Insom-
nia is also present in a number of neurological diseases such
as Alzheimer's disease and Parkinson's disease [1,2]. Insom-
nia includes difﬁculty falling asleep (prolonged sleep latency),
frequent awakenings (difﬁculty maintaining sleep), and shor-
tened sleep duration (resulting in daytime sleepiness, irrit-
ability and fatigue), all of which leads to impairments in
daytime functioning [1]. Almost any condition that affects
arousal and vigilance can induce insomnia [2].
Aside from comorbid neurological and psychiatric disor-
ders, risk factors generally include exposure to continued
stress. About half of the population experiences insomnia at
least half the nights, and about 5% meet clinical criteria. This
makes insomnia fairly common in modern society, and,
unfortunately, sleeping less than 4 h per night does increase
mortality [3]. There may be a genetic component since over
one half of patients diagnosed with primary insomnia
reported familial insomnia [4]. A number of imaging studies
suggest decreased frontal lobe function and/or hypofrontality
are present in insomnia [5,6].
The electroencephalographic (EEG) characteristics of
patients with insomnia do not show major differences
compared to good sleepers, with some studies reporting an
increase in low beta and decrease in high beta frequency
power [7], as well as decreases in REM sleep [8]. In general, the
differences in the EEG are subtle but do suggest intrusion of
higher frequency activity during low frequency states, such
as the incidence of higher beta activity during slow wave
sleep [9–11]. Experts in the ﬁeld agree that primary insomnia
patients not only show hyperarousal at night, but also during
the day, manifesting in part as the inability to nap despite
sleep deprivation symptoms [4,5]. This particular spectrum
suggests that there is high frequency activity during slow
wave sleep as well as decreased REM sleep, and the hyper-
arousal persists during waking. This is why we consider
insomnia a “waking disorder”, one in which the mechanisms
speciﬁcally driving waking are exaggerated [2].
Treatments for insomnia are palliative and include ben-
zodiazepines and non-benzodiazepine hypnotics to increase
sleep, but the risk of physical dependence is high when used
chronically [1]. However, from the foregoing discussion, it
appears that insomnia does tend to manifest speciﬁcally with
symptoms of excessive waking drive, rather than changes in
REM sleep drive.2. Hyperarousal and the reticular activating
system (RAS)
Given the information outlined above, what aspects of RAS
function will be involved in insomnia? There are ﬁve major
factors that apply to disorders involving the RAS. (1) We know
that the RAS participates in ﬁght-vs-ﬂight responses; therefore,
we would expect that responses to sudden alerting stimuli will
be abnormal. For disorders in which the RAS is overactive, this
would mean that such stimuli will produce exaggerated
responses that would be manifested as exaggerated startle
responses or hyperactive reﬂexes, such as the blink reﬂex. Fewsuch studies have been performed in patients with insomnia,
so we lack critical information about the condition. (2) Another
property of the RAS is its rapid habituation to repetitive
stimuli. This is reﬂected in its lack of responsiveness to rapidly
repeating stimuli, that is, its rapid habituation. This endows
the RAS with its capacity for sensory gating, the property of
decreasing responsiveness of repetitive events in favor of
novel or different stimuli. For disorders in which this property
is affected, we expect a decrease in habituation or a sensory
gating deﬁcit. Again, little information on this mechanism is
available for insomnia. (3) The RAS controls waking and sleep,
so that sleep patterns would be dysregulated. If the RAS is
down regulated by a disorder, we expect an inability to remain
awake, the presence of excessive daytime sleepiness, and an
excess of total sleep time, especially a decrease in slow wave
sleep. If, on the other hand, the RAS is up regulated, we expect
difﬁculty in getting to sleep and maintaining sleep. This would
be reﬂected in insomnia or disrupted sleep during the night,
and perhaps increased REM sleep drive, which is characterized
by vivid nightmares and frequent awakenings. Such a condi-
tion would lead to increased REM sleep drive during sleep
(resulting in intense dreaming), but perhaps also during
waking. That is, resulting in dreaming while awake or hallu-
cinations, along with hypervigilance. Patients with insomnia
do not appear to suffer from increased REM sleep drive or
hallucinations. Therefore, we assume that the dysregulation in
insomnia represents increased waking drive, instead. (4) The
RAS also modulates the maintenance of waking, a property
ignored by many investigators but one that affects a host of
functions. The inability to maintain a steady waking state, in
the form of maintained gamma band activity, will interfere
with attention, learning, and memory, to name a few pro-
cesses. The EEG studies mentioned above do suggest excessive
high frequency activity in insomnia, further emphasizing that
the disorder is one more related to the waking state.
(5) Another factor in all of these disorders is the level of
frontal lobe blood ﬂow. Decreased frontal lobe blood ﬂow, or
hypofrontality, is present in a number of disorders, e.g.
insomnia, schizophrenia, bipolar disorder, to some extent.
Such a state during waking would lead to reﬂexive reactions
with lack of consideration of consequences. This condition is
probably involved in a lack of habituation to repetitive stimuli,
or a sensory gating deﬁcit. Under the condition of decreased
cortical modulation, ﬁght-vs-ﬂight responses and reﬂexes
would be exaggerated. Whether hypofrontality is a cause of
RAS dysregulation or RAS dysregulation leads to hypofrontal-
ity remains to be determined. Decreased frontal lobe function
does appear to be present in insomnia, as described above
[5,6]. Moreover, successful treatment of the condition should
be marked by normalization of frontal lobe blood ﬂow.3. Pedunculopontine nucleus (PPN) physiology
and high frequency activity
The two most important advances on the physiology of the
RAS in the last 10 years were, (a) the discovery of electrical
coupling in some cells of certain RAS nuclei [12], and (b) the
ﬁnding that every cell in the same RAS nuclei manifests
intrinsic membrane beta/gamma oscillations [13]. These are
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channels that, when activated by depolarizing inputs, pro-
mote ﬁring at the peaks of the oscillations, i.e. at the natural
frequency of the oscillations, in this case, at beta/gamma
frequencies (20–60 Hz). The ﬁrst advance helps explain how
these brain centers manifest the coherence necessary to
maintain neuronal membrane oscillations at both low and
high frequencies. The second advance helps explain how
these nuclei induce and maintain gamma band activity
necessary for the process of awakening and remaining
awake. Since insomnia appears to be an increase in waking
drive, we will deal with the mechanisms that underlie high
frequency, beta/gamma activity in the PPN. Of the three main
nuclei in the RAS, the PPN, locus coeruleus, and raphe, it is
the PPN that is active during waking and REM sleep [14], the
two states of arousal that involve high frequency activity.
The PPN modulates ascending projections through the thala-
mus (modulating arousal) and descending projections through
the pons and medulla (modulating REM sleep and posture and
locomotion). The PPN ismade up of non-overlapping populations
of cholinergic, glutamatergic, and GABAergic neurons [15]. The
PPN contains three cell types based on in vitro intrinsic mem-
brane properties [16–18]. Recordings of PPN neurons in vivo
identiﬁed multiple types of thalamic-projecting PPN cells distin-
guished by their ﬁring properties relative to ponto-geniculo-
occipital (PGO) wave generation [19]. Some neurons exhibited
low spontaneous ﬁring frequencies (o10 Hz), but most showed
high rates of tonic ﬁring in the beta/gamma range (20–80 Hz). In
other in vivo studies, PPN neurons increased ﬁring during REM
sleep and were labeled “REM-on” cells, or during both waking
and REM sleep and were called “Wake/REM-on” cells, and also
during waking only and were called “Wake-on” cells [20–22].
Electrical stimulation of the PPNwill potentiate themanifestation
of fast (20–40 Hz) oscillations in the cortical EEG, outlasting
stimulation by 10–20 s [23]. These results suggest that PPN cells
do ﬁre at gamma band frequencies in vivo, and that its outputs
can indirectly induce gamma band activity in its targets.
We were the ﬁrst to report that all PPN cells ﬁred maximally
at gamma band frequency when depolarized using current steps
applied intracellularly to patch clamped neurons [24]. This is the
only property shared by every cell in the PPN, regardless of
transmitter type or electrophysiological type. Moreover, cells
around the PPN do not share that property [13,24,25]. Further
results demonstrated that both voltage-dependent N- and P/Q-
type calcium channels mediate the depolarizing phase of
gamma band oscillations in the PPN. However, only P/Q-type
channels appeared to be essential for gamma oscillation genera-
tion. Voltage clamp results suggested that calcium channels are
located distally to the cell body, probably in PPN dendritic
compartments [25], as has been determined in thalamic neurons
[26]. We then conﬁrmed using fast imaging techniques that PPN
calcium channel-mediated oscillations are due to P/Q- and N-
type channels, and revealed the fact that these channels are
distributed along the dendrites of PPN cells [27].4. Waking vs REM sleep high frequency
The differences between gamma band activities during waking vs
REM sleep are unknown. Why is this important? Because it ishigh frequency, especially beta/gamma band activity that drives
our cognitive function during waking but also during REM sleep,
two obviously different states. Our studies addressed the differ-
ential intracellular mechanisms assumed to subserve high fre-
quency activity during waking vs REM sleep as a prelude to the
selective pharmacological modulation of these states. In order to
develop an effective treatment for insomnia, we would need to
decrease waking drive, partially of course, without affecting REM
sleep drive. We know that the two states are differentially
regulated in the PPN, and the majority of this work was
performed by the Datta lab.
Injections of glutamate into the PPN were shown to increase
both waking and REM sleep, but injections of NMDA increased
only waking, while injections of kainic acid (KA) increased only
REM sleep [28–31]. Thus, the two states are independently
activated by NMDA vs KA receptors. Moreover, the intracellular
pathwaysmediating the two states appear to differ. For example,
the CaMKII activation inhibitor, KN-93, microinjected into the
PPN of freely moving rats resulted in decreased waking but not
REM sleep [32]. Increased ERK1/2 signaling in the PPN is asso-
ciated with maintenance of sleep via suppression of waking [33],
and that activation of intracellular protein kinase A (PKA) in the
PPN instead contributed to REM sleep recovery following REM
sleep deprivation [34]. These authors showed that during REM
sleep, pCREB activation in PPN cholinergic neurons was induced
by REM sleep, and that PPN intracellular PKA activation and a
transcriptional cascade involving pCREB occurred in cholinergic
neurons [35]. These results suggest that waking is modulated by
the CaMKII pathway while REM sleep is modulated by the cAMP-
PKA pathway in the PPN.
As mentioned above, in vivo recording studies have shown
that PPN neurons manifest three major types of cellular
activities in relation to waking and REM sleep in the form of
“Wake/REM on”, “Wake-on”, and “REM on” cells [20–22]. This
suggests that some PPN cells ﬁre in relation to waking and
REM sleep, only in relation to waking, and others only in
relation to REM sleep, presumably through CaMKII and cAMP-
PKA pathways vs only the cAMP-PKA pathway, respectively.
We have breakthrough ﬁndings showing that in some PPN
cells (50%), the N-type calcium channel blocker ω-conotoxin-
GVIA (ω-CgTx) reduced gamma oscillation amplitude, while
subsequent addition of the P/Q-type blocker ω-agatoxin-IVA
(ω-Aga) blocked the remaining oscillations. Other PPN cells
(20%) manifested gamma oscillations that were not signiﬁ-
cantly affected by the addition of ω-CgTx, however, ω-Aga
blocked the remaining oscillations. In the rest of the cells
(30%), ω-Aga had no effect on gamma oscillations, while
ω-CgTx blocked them. Similar results were found during
recordings of voltage-dependent calcium currents. These
results conﬁrm the presence of cells in the PPN that manifest
gamma band oscillations through only N-type, only P/Q-type,
and both N- and P/Q-type calcium channels [36,37]. This new
cell type classiﬁcation suggests that some PPN neurons ﬁre
only during REM sleep (“REM-on”, N-type only), only during
waking (“Wake-on”, P/Q-type only), or during both waking and
REM sleep (“Wake/REM-on”, N-typeþP/Q-type) [36,37]. Fig. 1
shows the responses to depolarizing ramps in each of these
cell types, with responses being mediated by both N- and P/Q-
type calcium channels (partial block by each channel blocker),
by N-type only (complete block by ω-CgTx), and by P/Q-type
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and main intracellular control pathways modulating the two
channel types, and presumed in vivo ﬁring patterns.5. Two calcium channels
N- and P/Q-type calcium channel subtypes both are linked to
rapid release of synaptic vesicles [38,39], but knockout models
manifest markedly different phenotypes [40]. P/Q-type
(Cav2.1) knockout animals have deﬁcient gamma band activ-
ity in the EEG, abnormal sleep-wake states, ataxia, are prone
to seizures (low frequency synchrony), and die by 3 weeks of
age [41,42]. On the other hand, N-type (Cav2.2) knockout
animals show few sleep-wake abnormalities but exhibitFig. 1 – PPN cells manifest gamma band activity through N- and
Membrane oscillations recorded during 1 s long ramps in the pr
black). Following superfusion with ω-CgTx for 10 min, oscillatio
Thereafter, ω-Aga was superfused for 10 min blocking the rema
Membrane oscillations recorded during 1 s long ramps in the pr
black). ω-Aga applied into the bath for 10 min caused no signiﬁc
gray), that is, the oscillations are NOT reduced by ω-Aga. ω-CgTx w
of the membrane oscillations (right record, light gray). Bottom, P
ramps in the presence of synaptic blockers and tetrodotoxin (le
signiﬁcant effect on the oscillations (middle record, dark gray), th
was superfused for 10 min causing a complete blockade of thedecreased nociceptive responses, and are otherwise normal
[40]. While the two types of receptors are modulated by G-
protein coupled receptors, they require different G-protein
subunits [43]. Intracellularly, protein kinase C (PKC) enhances
N-type channel activity but has no effect on P/Q-type channel
function [44], but CaMKII was shown to modulate P/Q-type
channel function [45]. Again, the two calcium channel sub-
types are modulated by different intracellular pathways, N-
type by the cAMP/PK pathway, and P/Q-type via the CaMKII
pathway. The implication from all of these results is that
there is a “waking” pathway mediated by CaMKII and P/Q-
type channels, and a “REM sleep” pathway mediated by
cAMP/PK and N-type channels.
Interestingly, PPN cells with N-type channels only mani-
fested oscillations in the 50 Hz range, while cells with P/Q-P/Q-, N-only, and P/Q-only type Ca2þ channels. Top, NþP/Q).
esence of synaptic blockers and tetrodotoxin (left record,
n amplitude was reduced (middle record, dark gray).
ining oscillations (right record, light gray). Middle, N-only)
esence of synaptic blockers and tetrodotoxin (left record,
ant effect on the membrane oscillations (middle record, dark
as then superfused for 10 min, causing a complete blockade
/Q-only) Membrane oscillations recorded during 1 s long
ft record, black). ω-CgTx was applied for 10 min causing no
at is, the oscillations are NOT reduced by ω-CgTx. ω-Aga then
membrane oscillations (right record, light gray).
Fig. 2 – PPN cell types manifesting P/Q-type channels only,
N-type channels only, or N- and P/Q-type channels. PPN
cells with only P/Q-type calcium channels numbered 20%,
and are assumed to be “Wake-on” and modulated by
CaMKII. PPN cells with both N- and P/Q-type calcium
channels numbered 50%, and are assumed to be Wake/REM-
on” and modulated by both CaMKII and cAMP/PKA
metabolic pathways. PPN cells with only N-type calcium
channels numbered 30%, and are assumed to be “REM-on”
and modulated by the cAMP/PKA pathway. P/Q-only and
NþP/Q cells thus are expected to be active during waking,
while N-only and NþP/Q cells are active during REM sleep.
Fig. 3 – Intracellular pathways modulated by different
glutamatergic receptors that drive independent calcium
channel types. As discussed above, a wealth of information
is available to suggest that NMDA promotes waking in the
PPN and that this effect is mediated by CaMKII, and that
kainic acid promotes REM sleep and that this effect is
mediated by cAMP/PKA. Both of these pathways interact
with the release of calcium from the endoplasmic reticulum
(ER) induced by inositol phosphate 3 (IP3) release from the
membrane and binding to the IP3 receptor. In addition, P/Q-
type channels are modulated by CaMKII while N-type
channels are modulated by cAMP/PKA. This points to a
selective participation of P/Q-type channels in generating
gamma band activity during waking, and N-type channels
generating gamma band activity during REM sleep.
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while cells with both N- and P/Q-type channels showed
oscillations in the 37 Hz range. These results suggest that
each channel type may have a preferred oscillation fre-
quency, but when channels coexist they may manifest lower
frequencies, perhaps due to competition and/or differential
location along dendrites [27]. Fig. 3 provides a diagram of the
intracellular “waking” pathway and the “REM sleep” pathway,
and their modulation of different calcium channel types by
separate glutamatergic receptor types. With this information,
we can now attempt to selectively modulate waking by
affecting P/Q-type calcium channels and/or the CaMKII path-
way, or modulate REM sleep by affecting the N-type calcium
channels and/or the cAMP/PK pathway.
This organization has implications of the differential
control of waking vs REM sleep for the developmental
decrease in REM sleep seen in between birth and young
adulthood. This hypothesis suggests that, early in develop-
ment, there is increased expression of N-type channels
driving exuberant REM sleep that decrease with age. This
could be demonstrated by a decrease in N-type calcium
channel expression compared to P/Q-type channel expres-
sion, but speciﬁcally in regions controlling REM sleep such as
the PPN, but not in other regions.6. Novel treatments for insomnia
Given the foregoing discussion, it would appear that the
excessive waking drive in insomnia may be mediated byincreased activity in the “waking” pathway, either by over
expression of P/Q-type calcium channels, over activity in
CaMKII modulation of these channels, and/or overdriving of
this pathway by another intracellular mechanism.
One such mechanism involves neuronal calcium sensor
protein 1 (NCS-1), an intracellular modulator of calcium
metabolism, that at low concentrations potentiates beta/
gamma oscillations in PPN neurons [46,47]. In insomnia, there
may be a dysregulation in this protein that leads to increased
high frequency activity. NCS-1 has been shown to be over
expressed in schizophrenia and bipolar disorder [48], such
that high concentrations of NCS-1 will down regulate gamma
band activity [46], and lithium will down regulate the effects
of NCS-1 over expression [49]. That is, lithium appears to
down regulate excessive NCS-1 to normalize high frequency
activity. The use of lithium to alleviate the hypervigilance in
schizophrenia and bipolar disorder may also modulate the
hyperarousal in insomnia. However, dosage may need to be
very low in order to only partially reduce high frequency
activity, and to minimize the risk of toxicity. Hopefully, future
off label and clinical trials may prove beneﬁcial in this
difﬁcult to treat condition, but better animal models of
insomnia need to be developed. For example, a genetic
mouse model in which over expression of P/Q-type calcium
channels can be generated or conditionally induced could be
a very valuable approach.
Another potential avenue of treatment for insomnia is the
modulation of the CaMKII “waking” pathway. The increased
Fig. 4 – Proposed organization of cell ensembles in the PPN
containing cells that express only N-type, only P/Q-type, or
both calcium channels subtypes. Glutamatergic neurons are
shown as red circles, cholinergic neurons as blue hexagons,
and GABAergic cells as green ovals, some being electrically
coupled (black bars). Groups of cells with a 5:3:2 ratio would
all need to express the same channels subtype. Ensembles
expressing only N-type channels would ﬁre during REM
sleep (REM-on), those expressing only P/Q-type channels
would ﬁre during waking (Wake-on), and those expressing
both would ﬁre during each state (Wake/REM-on).
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CaMKII pathway is over activated in relation to the cAMP/PKA
pathway. This pathway can be inhibited by KN-93 [47], so that
mild down regulation of CaMKII may provide beneﬁcial
results in insomnia. This is clinically difﬁcult because of the
many functions of CaMKII, so that other approaches may be
needed unless more speciﬁc agents are forthcoming. A
different approach would be partial blockade of P/Q-type
calcium channels to reduce gamma oscillations and, there-
fore, arousal. New agents must be developed to elicit such
effects, mimicking the speciﬁcity of agatoxin. In summary,
this review provides a novel outlook on insomnia as a
disorder of waking rather than sleep. This naturally points
to a host of information that needs to be gathered (reﬂex
function, startle response, sensory gating), and to novel
therapeutic targets (P/Q-type channels, CaMKII, NCS-1) for
the treatment of this condition. There may be additional, yet
unrecognized, intracellular mechanisms that induce over
activity in the function of P/Q-type calcium channels and its
pathway, and these can only be identiﬁed with further
research. These recent ﬁndings provide a likely target for
such research. In addition, it would be interesting to deter-
mine if non-pharmacological therapies such as Cognitive-
Behavioral Therapy for Insomnia can modify gamma band
activity.7. Additional implications- cell ensembles
While there are three electrophysiological types of PPN cells
in vitro, each of these is represented in the N-only, P/Q-only
and NþP/Q cell groups, suggesting that all of the electrophy-
siological cell types are found in each cell ensemble. Anato-
mically, neurons in the PPN are scattered such that in the pars
compacta there are glutamatergic (GLU), cholinergic (ACh), and
GABAergic neurons in the ratio of 5:3:2, respectively [13]. Since
all three electrophysiological types are included in the calcium
channel segregation, it also means that all of the transmitter
types are represented in the calcium channel segregation. This
suggests that there are ensembles of N-only cells with gluta-
matergic, cholinergic, and GABAergic cells, and similarly for
P/Q-only and NþP/Q cells. Studies using calcium imaging in
the PPN pars compacta reveal an interesting anatomical orga-
nization within the nucleus. Pairs of PPN cells are labeled
throughout the nucleus even in the control, unstimulated
condition [48]. The spatial separation between couplets sug-
gests that there are clusters of cells throughout the nucleus.
Since electrically coupled neurons generally represent
GABAergic neurons, we speculate that there are 5 GLU and 3
ACh neurons closely associated with each GABAergic pair.
That is, there may be clusters of approximately 10 neurons
scattered within the pars compacta that may create a functional
subgroup. These functional subgroups may each bear a differ-
ent combination of calcium channels. Much additional evi-
dence is required to support this hypothesis, but it may be
possible to dissect such an organization to determine how the
nucleus as a whole generates coherent activity at speciﬁc
frequencies. It is also important to determine how PPN
neurons respond to sensory input and how that input gen-
erates coherent activity. Fig. 4 provides a proposedorganization for these groups, each of which would includes
each transmitter type, but all of the cells within the group
would express one or both of the channels.
Similar functional clustering has been proposed for the
hippocampus, especially in relation to epileptic networks [50].
In a study of cell assemblies in the hippocampus, Buzsaki
described subsets of about 10 neurons that showed repeated
synchronous ﬁring during open ﬁeld exploration [51]. Inter-
estingly, the timescale of activity between these neurons had
a median of 23 ms, and the peak optimal timescale was
16 ms, that is, most activity occurred in the 40–60 Hz range.
We hypothesize that a similar temporal relationship will be
evident among cell clusters in the PPN. Moreover, we postu-
late that there are cell ensembles of 5 GLU, 3 ACh, and 2 GABA
cells all of which have N-only calcium channels, representing
a cluster ﬁring during REM sleep only (REM-on cluster), and
similar ensembles which have only P/Q-type channels that
ﬁre only during waking (Wake-on cluster), and ensembles
which have both N- and P/Q-type calcium channels that ﬁre
during waking and REM sleep (Wake/REM-on clusters). We
proposed that each ensemble manifests N-only, P/Q-only, or
both NþP/Q calcium channels [2].8. Conclusion
The implications of the discovery of gamma band activity as
a ubiquitous mechanism in RAS nuclei that modulate waking
and REM sleep, and activate the cortex as well as postural and
locomotor systems, are of critical importance. The fact that
these centers can generate gamma band oscillations, how-
ever, should not be surprising given the descriptions of
gamma activity in other subcortical structures such as the
cerebellum, hippocampus, and the basal ganglia. Moreover,
gamma band activity between these regions is coherent, so
S l e e p S c i e n c e 8 ( 2 0 1 5 ) 9 2 – 9 998that RAS gamma band activity is probably highly coordinated
with cortical and other subcortical gamma band generators,
depending on the task. This also should not be surprising,
given the need for reverberating circuits and cell assemblies
essential for the persistence or maintenance of processes
that mediate perception, movement, learning, and memory.
These issues are discussed at length in a recent book [2]. The
process of maintaining gamma band activity is metabolically
demanding. PPN neurons must remain highly active during
the waking state. Waking is hard work. When these neurons
are over active, the consequences are wide-ranging and
exhausting, in keeping with the consequences of increased
waking drive in insomnia and sleep-deprivation symptoms.
This review strengthens the need to revisit the physiological
mechanisms governing the wake/sleep cycle because of the
impact it could have on a number of psychiatric and neuro-
logical disorders.Acknowledgments
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